Filing Details

Accession Number:
0000899243-18-005874
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-28 19:34:58
Reporting Period:
2018-02-26
Accepted Time:
2018-02-28 19:34:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1552451 Myokardia Inc MYOK Pharmaceutical Preparations (2834) 455500552
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654909 Jake Bauer C/O Myokardia, Inc.
333 Allerton Avenue
South San Francisco CA 94080
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-26 5,102 $9.08 66,879 No 4 M Direct
Common Stock Disposition 2018-02-26 5,102 $60.00 61,777 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-02-26 5,102 $0.00 5,102 $9.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
28,912 2026-02-01 No 4 M Direct
Footnotes
  1. This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  2. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments with the first installment on February 1, 2016, such that this option is fully exercisable on January 1, 2020.